(Q37903707)

25 August 2017

1 reference

title

Inhibition of advanced glycation endproduct formation by foodstuffs (English)

1 reference

25 August 2017

1

Chi-Hao Wu

1 reference

25 August 2017

Shang-Ming Huang

2

1 reference

PubMed ID

21779560

25 August 2017

Jer-An Lin

series ordinal

3

1 reference

PubMed ID

21779560

25 August 2017

Gow-Chin Yen

series ordinal

4

1 reference

25 August 2017

8 April 2011

1 reference

25 August 2017

1 reference

25 August 2017

2

1 reference

25 August 2017

5

1 reference

25 August 2017

224-234

1 reference

Five years of research on health risks and benefits of Maillard reaction products: an update.

25 August 2017

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Evidence against dietary advanced glycation endproducts being a risk to human health

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Glucose and reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Amadorins: novel post-Amadori inhibitors of advanced glycation reactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Dietary antioxidant intake and risk of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Influence of postharvest processing and storage on the content of phenolic acids and flavonoids in foods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Inhibitory effect of naturally occurring flavonoids on the formation of advanced glycation endproducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Toxicity of the AGEs generated from the Maillard reaction: on the relationship of food-AGEs and biological-AGEs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Arguing for the motion: yes, RAGE is a receptor for advanced glycation endproducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Investigation of pathways of advanced glycation end-products accumulation in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Advanced glycation endproduct crosslinking in the cardiovascular system: potential therapeutic target for cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Trapping reactions of reactive carbonyl species with tea polyphenols in simulated physiological conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Tea polyphenol (-)-epigallocatechin-3-gallate: a new trapping agent of reactive dicarbonyl species

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Advanced glycation endproducts (AGEs): Pharmacological inhibition in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

The mechanism by which dietary AGEs are a risk to human health is via their interaction with RAGE: arguing against the motion

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Cinnamon: potential role in the prevention of insulin resistance, metabolic syndrome, and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Cinnamon bark proanthocyanidins as reactive carbonyl scavengers to prevent the formation of advanced glycation endproducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Beneficial effects of cinnamon proanthocyanidins on the formation of specific advanced glycation endproducts and methylglyoxal-induced impairment on glucose consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Antiglycative and anti-VEGF effects of s-ethyl cysteine and s-propyl cysteine in kidney of diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Antioxidative and antiglycative effects of six organosulfur compounds in low-density lipoprotein and plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Attenuation of streptozotocin-induced oxidative stress in hepatic and intestinal tissues of Wistar rat by methanolic-garlic extract

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Yerba Mate Tea (Ilex paraguariensis): a comprehensive review on chemistry, health implications, and technological considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Ilex paraguariensis extracts inhibit AGE formation more efficiently than green tea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Caffeic and chlorogenic acids in Ilex paraguariensis extracts are the main inhibitors of AGE generation by methylglyoxal in model proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Protein glycation inhibitory and antioxidative activities of some plant extracts in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Inhibition of protein glycation by extracts of culinary herbs and spices

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Protective activity of green tea against free radical- and glucose-mediated protein damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Green tea extract suppresses the age-related increase in collagen crosslinking and fluorescent products in C57BL/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Green tea impedes dyslipidemia, lipid peroxidation, protein glycation and ameliorates Ca2+ -ATPase and Na+/K+ -ATPase activity in the heart of streptozotocin-diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Effect of green tea extract on advanced glycation and cross-linking of tail tendon collagen in streptozotocin induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Black and green teas equally inhibit diabetic cataracts in a streptozotocin-induced rat model of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Matcha, a powdered green tea, ameliorates the progression of renal and hepatic damage in type 2 diabetic OLETF rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Tomato paste fraction inhibiting the formation of advanced glycation end-products

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Antioxidant and antiglycation properties of total saponins extracted from traditional Chinese medicine used to treat diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Glycation inhibitory activity and the identification of an active compound in Plantago asiatica extract

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Inhibitory effects of Luobuma tea and its components against glucose-mediated protein damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Multifaceted therapeutic benefits of Ginkgo biloba L.: chemistry, efficacy, safety, and uses

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Effects of ginkgo biloba extract EGb761 on expression of RAGE and LRP-1 in cerebral microvascular endothelial cells under chronic hypoxia and hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Central role of PKCdelta in glycoxidation-dependent apoptosis of human neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Stilbene glucoside from Polygonum multiflorum Thunb.: a novel natural inhibitor of advanced glycation end product formation by trapping of methylglyoxal

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Carnosine and its constituents inhibit glycation of low-density lipoproteins that promotes foam cell formation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Chelating activity of advanced glycation end-product inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Molecular dynamics and information on possible sites of interaction of intramyocellular metabolites in vivo from resolved dipolar couplings in localized 1H NMR spectra

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Glucose, glycation and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Glycation, ageing and carnosine: are carnivorous diets beneficial?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Histidine and carnosine delay diabetic deterioration in mice and protect human low density lipoprotein against oxidation and glycation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Therapeutic uses of drug-carrier systems for imidazole-containing dipeptide compounds that act as pharmacological chaperones and have significant impact on the treatment of chronic diseases associated with increased oxidative stress and the formatio

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Efficacy of turmeric on blood sugar and polyol pathway in diabetic albino rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Curcumin prevents streptozotocin-induced islet damage by scavenging free radicals: a prophylactic and protective role

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Influence of tetrahydrocurcumin on tail tendon collagen contents and its properties in rats with streptozotocin-nicotinamide-induced type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Curcumin supplementation lowers TNF-alpha, IL-6, IL-8, and MCP-1 secretion in high glucose-treated cultured monocytes and blood levels of TNF-alpha, IL-6, MCP-1, glucose, and glycosylated hemoglobin in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Naturally occurring flavonoids attenuate high glucose-induced expression of proinflammatory cytokines in human monocytic THP-1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Low-density-lipoprotein (LDL)-bound flavonoids increase the resistance of LDL to oxidation and glycation under pathophysiological concentrations of glucose in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Dietary phenolic acids attenuate multiple stages of protein glycation and high-glucose-stimulated proinflammatory IL-1beta activation by interfering with chromatin remodeling and transcription in monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Silymarin: a novel antioxidant with antiglycation and antiinflammatory properties in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Structural requirements of flavonoids for inhibition of protein glycation and radical scavenging activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Rutin metabolites: novel inhibitors of nonoxidative advanced glycation end products

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Two Flavone C-Glycosides from the Style of Zea mays with Glycation Inhibitory Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Anti-glycative and anti-inflammatory effects of caffeic acid and ellagic acid in kidney of diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Cytoprotective effects of phenolic acids on methylglyoxal-induced apoptosis in Neuro-2A cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Inhibitory effect of vanillic acid on methylglyoxal-mediated glycation in apoptotic Neuro-2A cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Silybin and silymarin--new and emerging applications in medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Astragalosides isolated from the root of astragalus radix inhibit the formation of advanced glycation end products

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Therapeutic potential of 20(S)-ginsenoside Rg(3) against streptozotocin-induced diabetic renal damage in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Protective effect of heat-processed American ginseng against diabetic renal damage in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Oleanolic acid and ursolic acid: research perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Oleanolic acid and ursolic acid induce apoptosis in HuH7 human hepatocellular carcinoma cells through a mitochondrial-dependent pathway and downregulation of XIAP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Ursolic acid, a naturally occurring triterpenoid, suppresses migration and invasion of human breast cancer cells by modulating c-Jun N-terminal kinase, Akt and mammalian target of rapamycin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Anti-glycative effects of oleanolic acid and ursolic acid in kidney of diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Inhibitory effects of ursolic acid on hepatic polyol pathway and glucose production in streptozotocin-induced diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Molecular aspects of lipoic acid in the prevention of diabetes complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Vitamin E reduction of protein glycosylation in diabetes. New prospect for prevention of diabetic complications?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Protective effect of vitamin E supplementation on increased thermal stability of collagen in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Benazepril, an angiotensin-converting enzyme inhibitor, alleviates renal injury in spontaneously hypertensive rats by inhibiting advanced glycation end-product-mediated pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Milk protein peptides with angiotensin I-converting enzyme inhibitory (ACEI) activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Mechanistic Studies of Advanced Glycosylation End Product Inhibition by Aminoguanidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Design and baseline characteristics for the aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Effects of OPB-9195, anti-glycation agent, on experimental diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Role of the AGE crosslink breaker, alagebrium, as a renoprotective agent in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Novel inhibitors of glycation and AGE formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Inhibition of non-enzymatic glycation by silk extracts from a Mexican land race and modern inbred lines of maize (Zea mays)

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1FO10026B

Chemical constituents of the style of Zea mays L. with glycation inhibitory activity

21 January 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.55.153

Identifiers

DOI

10.1039/C1FO10026B

1 reference

25 August 2017

1 reference

PubMed ID

21779560